Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patients.
Asia Pac Psychiatry. 2019 Jun;11(2):e12352. doi: 10.1111/appy.12352. Epub 2019 Apr 4.
Asia Pac Psychiatry. 2019.
PMID: 30950208
Clinical Trial.